Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 357 (9274) , 2085-2089
- https://doi.org/10.1016/s0140-6736(00)05181-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Microimmunofluorescence Test forChlamydia pneumoniaeInfection: Technique and InterpretationThe Journal of Infectious Diseases, 2000
- Decreased neointimal formation in Mac-1–/– mice reveals a role for inflammation in vascular repair after angioplastyJournal of Clinical Investigation, 2000
- The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniaeJournal of Clinical Investigation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Interlesion Dependence of the Risk for Restenosis in Patients With Coronary Stent Placement in Multiple LesionsCirculation, 1998
- Endovascular Presence of Viable Chlamydia pneumoniaeIs a Common Phenomenon in Coronary Artery Disease 11This study was supported in part by the Research Commission of the Medical University of Lübeck (8/96) and the Deutsche Forschungsgemeinschaft (SFB 367/B2), Bonn, Germany.Journal of the American College of Cardiology, 1998
- Chronic arterial responses to stent implantation: A serial intravascular ultrasound analysis of palmaz-schatz stents in native coronary arteriesJournal of the American College of Cardiology, 1996
- Patterns and Mechanisms of In-Stent RestenosisCirculation, 1996
- Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis modelJournal of the American College of Cardiology, 1994
- Time course of restenosis during the first year after emergency coronary stenting.Circulation, 1993